METRONIDAZOLE 1%w/w IP + SUCRALFATE 7%w/w IP + POVIDONE IODINE 5%w/w IP

A topical antimicrobial formulation for the treatment and prevention of a variety of skin infections, burns, and wounds. Inhibits the growth of infection-causing microbes such as bacteria, fungi, viruses, and protozoa. (Didier Lepelletier, 2020) A highly effective treatment for acute and chronic wounds due to its rapid, potent, broad-spectrum antimicrobial properties. (Paul Lorenz Bigliardi, 2017) A promising agent for the management of antisepsis, tackling antimicrobial resistance, and eradicating bacterial biofilms in acute and chronic wound care. (Ruben Barreto, 2020) Prevents the growth of microorganisms and promotes early wound healing. An effective agent that reduces odour, exudate, and pain in patients with a wide variety of wounds. (Ousey, 2018) Prevents the release of inflammatory cytokines from damaged epithelial cells that lessens the severity of pain and promotes wound healing. (Amir K. Vejdan, 2020) Provides relief from pain, swelling, redness, and itchiness in the affected area and speeds up the healing process. Soothes burning sensation and reduces patient discomfort in burn patients. (Mahim Koshariya, 2015)